We are live on ! Find out more
FCM

Fourpath Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 29.98%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+29.98%
3 Year Est. Return
+72.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$2.97M
Cap. Flow
-$10.8M
Cap. Flow %
-7.46%
Top 10 Hldgs %
48.25%
Holding
148
New
12
Increased
38
Reduced
78
Closed
8

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$530K
2
FJUL icon
FT Vest US Equity Buffer ETF July
FJUL
+$508K
3
GILD icon
Gilead Sciences
GILD
+$351K
4
TGT icon
Target
TGT
+$267K
5
LLY icon
Eli Lilly
LLY
+$238K

Top Sells

Rank Stock Value
1
RWM icon
ProShares Short Russell2000
RWM
+$3.92M
2
SJB icon
ProShares Short High Yield
SJB
+$2.41M
3
SH icon
ProShares Short S&P500
SH
+$2.23M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$1.35M
5
MDT icon
Medtronic
MDT
+$565K

Sector Composition

Rank Sector Weight
1 Energy 16.92%
2 Technology 8.48%
3 Financials 6.92%
4 Healthcare 6.43%
5 Consumer Staples 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNY icon
51
Sanofi
SNY
$107B
$656K 0.46%
13,499
+4,562
+51% +$223K
CRWD icon
52
CrowdStrike
CRWD
$207B
$655K 0.45%
8,168
-784
-9% -$60K
TFC icon
53
Truist Financial
TFC
$64.1B
$651K 0.45%
16,712
-337
-2% -$12.3K
JPM icon
54
JPMorgan Chase
JPM
$907B
$605K 0.42%
3,018
-467
-13% -$84.3K
O icon
55
Realty Income
O
$61.3B
$602K 0.42%
11,128
+2,440
+28% +$132K
V icon
56
Visa
V
$682B
$599K 0.42%
2,147
-10
-0.5% -$2.76K
SPYM
57
State Street SPDR Portfolio S&P 500 ETF
SPYM
$159B
$584K 0.41%
9,498
-169
-2% -$9.9K
BTI icon
58
British American Tobacco
BTI
$136B
$583K 0.4%
19,110
-3,967
-17% -$119K
ETR icon
59
Entergy
ETR
$52.8B
$578K 0.4%
10,930
-268
-2% -$13.6K
GWW icon
60
W.W. Grainger
GWW
$65.9B
$570K 0.4%
560
+155
+38% +$144K
BMY icon
61
Bristol-Myers Squibb
BMY
$124B
$564K 0.39%
+10,407
New +$530K
PPL
62
PPL Corp
PPL
$27B
$564K 0.39%
20,494
-340
-2% -$9.05K
CM icon
63
Canadian Imperial Bank of Commerce
CM
$111B
$543K 0.38%
10,707
-177
-2% -$8.36K
KVUE icon
64
Kenvue
KVUE
$36.4B
$529K 0.37%
24,633
+5,974
+32% +$121K
JAAA icon
65
Janus Henderson AAA CLO ETF
JAAA
$29.1B
$528K 0.37%
10,403
-54
-0.5% -$2.73K
FJUL icon
66
FT Vest US Equity Buffer ETF July
FJUL
$1.19B
$526K 0.36%
+11,830
New +$508K
PG icon
67
Procter & Gamble
PG
$349B
$520K 0.36%
3,207
– –
CMCSA icon
68
Comcast
CMCSA
$85B
$511K 0.35%
11,786
-1,687
-13% -$72.8K
NFLX icon
69
Netflix
NFLX
$290B
$507K 0.35%
8,340
-510
-6% -$28.8K
SPG icon
70
Simon Property Group
SPG
$74.2B
$505K 0.35%
3,225
– –
TEL icon
71
TE Connectivity
TEL
$59.3B
$494K 0.34%
3,401
-34
-1% -$4.76K
ADSK icon
72
Autodesk
ADSK
$46.1B
$493K 0.34%
1,895
-20
-1% -$5.06K
FLRN icon
73
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.07B
$479K 0.33%
15,527
-76
-0.5% -$2.33K
CAG icon
74
Conagra Brands
CAG
$6.83B
$472K 0.33%
15,933
+3,664
+30% +$105K
HUBS icon
75
HubSpot
HUBS
$11.5B
$472K 0.33%
753
-7
-0.9% -$4.21K
1 2
3
4 5

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
AIA
Allied Investment Advisors Billings, Montana $697M AUM 21.33% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return

Fourpath Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Fourpath Capital Management held 148 positions worth $144M, down 2% from $147M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Fourpath Capital Management withdrew a net $10.8M in Q1 2024, closing 8 positions and reducing 78 holdings. Its most notable exit was Medtronic, an estimated $565K position sold in full.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Fourpath Capital Management opened a new position in Bristol-Myers Squibb worth $564K.

  • Fourpath Capital Management's largest Q1 2024 buy was Bristol-Myers Squibb: 10,407 shares worth $564K.
  • Fourpath Capital Management added most to Gilead Sciences in Q1 2024, an estimated $351K increase.
  • Fourpath Capital Management's biggest Q1 2024 reduction was ProShares Short Russell2000, cutting an estimated $3.92M.
  • Fourpath Capital Management fully exited Medtronic in Q1 2024, selling an estimated $565K.
  • Fourpath Capital Management's ten largest holdings make up 48% of its $144M portfolio in Q1 2024.
  • Fourpath Capital Management opened 12 new positions and closed 8 in Q1 2024.
  • Fourpath Capital Management's portfolio value fell 2% quarter-over-quarter to $144M.

Based on Fourpath Capital Management's 13F filing for Q1 2024, filed 7 May 2024.